Registration has been opened now!
【Information 】We will hold the 6th COINS Symposium.
Date: Dec 13 (Fri.) 13:00～(Registration open at 12:30)
Venue: Kawasaki City Industrial Promotion Hall Access
language: English - Japanese *Simultaneous interpretation is provided.
Registration has been opened now!
【Information 】We will hold the COINS Seminar #49 at iCONM.
October 24 (Thu.) 16:00-17:15／Research Mixer 17:15-18:15 *JPY500
Speaker: Prof. Dr. Rainer Haag／Chair Professor of Organic and Macromolecular Chemistry, Department of Chemistry and Biochemistry, Freie Universität Berlin, Germany
Title: Multivalent Nanosystems and Supramolecular Dendritic Architectures
Venue: Innovation Center of NanoMedicine (iCONM) 3F 3001 Access Click here for details 【Reservation is required】Registration
【Information 】At The National Museum of Emerging Science and Innovation known as "Miraikan" (Aomi, Koto-ku, Tokyo), an opinion bank about the "In-body hospitals" that iCONM draws for the future is now oepn to the public. We look forward to your feedback, as we will gather the voices of visitors to the museum and use them for future research.
【Press release】The article about Dr. Yasutaka Anraku (Project Professor, The University of Tokyo), who is a leader of COINS Theme 2 was appeared in JSTnews.
【Information】On Wednesday, October 9 - Friday, October 11, iCONM participates in BioJapan 2019, which is Asia's largest event in bio business to be held at Pacifico Yokohama. Please visit us.
Booth No: D-30 / Exhibition booth: Yokohama・Kawasaki pavilion
【Information】We declare October 2019 to be "Compliance Awareness Month" and conduct activities to promote compliance with research ethics and use of public research expenses. Click here for details
【Report】Articles about Prof. Ken Masamune (Professor, Tokyo Women's Medical University)who is a member of our center's COINS project,Published in the magazine Pharmaceutical Economics.
Integrate information to predict postoperative. Practitioner of medical-industrial collaboration 6 Ken Masamune, Professor, Tokyo Women's Medical University.
【Report】An interview with Dr.Shiro Akinaga, President of AccuRna, Inc., the main project COINS, was published in the Nikkei Business Daily.
Dr.Shiro Akinaga, President of AccuRna, Inc.,－Nucleic acid medicine in clinical settings | Nikkei Business Daily
【Award】Akira Matsumoto, Associate Professor (Tokyo Medical and Dental University),received 68th SPSJ Annual Meeting of the Publicity Award.
Title：Microneedle type “just stick” artificial pancreas: dramatically improved invasiveness, stability, economy and aesthetics
【Activity Report】Sep 5th (Thu.), COINS Seminar #48 was held at iCONM.
Speaker: Dr. Hiroaki Taniguchi
Project Associate Professor, Keio Cancer Center & Clinical and Translational Research Center, Keio University School of Medicine..
Title: " PRDM14 silencing by siRNA combined with an innovative nanoparticle reduced tumor formation and metastasis " Click here for details
【Activity Report】In August, the members of Kawasaki City Elementary School Japan Social Study Research Association, Foundation for Biomedical Research and Innovation at Kobe, Ministry of Finance, Japan Budget Bureau and the students of Seiritsu Gakuen High School visited iCONM. Click here for details
【Activity Report】Aug 28th (Wed.), COINS Seminar #47 was held at iCONM.
Speaker: Hiroo Iwata
Dr. Eng. / Manager, Strategy Research Support Section of Center of Innovation Program, Kyoto U.
Title: " Cell Lego "
Speaker: Peilin Chen
Professor / Research Fellow, Research Center for Applied Sciences, Academia Sinica, Taiwan.
Title: " Isolation of Rare Cells: Toward Noninvasive Diagnostic " Click here for details
【Activity Report】Takuya HIRAI（Minister in charge of Information Technology Policy, "Cool Japan" Strategy, the Intellectual Property Strategy, Science and Technology Policy, Space Policy）visited King Skyfront.
【Press release】AccuRna Inc. announced that the company enters into a Feasibility Study Agreement with Astellas Innovation Management LLC subsidiary of Astellas Pharma Inc for the use of delivery system of polymer micelle1 loaded with messenger RNA (mRNA) under pre-clinical development by AccuRna. Press release text
【Award】Dr. Junjie Li, a JSPS Postdoctoral Fellow for Research in Japan received CASNN Best Poster Award at Chinese-American Society of Nanomedicine and Nanobiotechnology 2019 Annual Conference held on August 19 – 22 in Hangzhou, China. He proposed the method that accurately distinguishes cancer tissue from normal tissue and attacks only cancer tissue with high accuracy by the experiments with multifunctional nanocarriers. Related page is here.
【Report】Articles about Prof. Kouhei Soga (Professor, Tokyo University of Science)who is a member of our center's COINS project,Published in the magazine Pharmaceutical Economics.
In-vivo imaging with near-infrared. Practitioner of medical-industrial collaboration 4 Kouhei Soga, Professor, Tokyo University of Science.
【Information 】We will hold the COINS Seminar #48 at iCONM.
September 5 (Thu.) 16:00-17:15／Research Mixer 17:15～18:15 *JPY500
Speaker: Hiroaki Taniguchi／Project Associate Professor, Keio Cancer Center & Clinical and Translational Research Center, Keio University School of Medicine.
Title: PRDM14 silencing by siRNA combined with an innovative nanoparticle reduced tumor formation and metastasis
【Information 】We will hold the COINS Seminar #47 at iCONM.
August 28 (Wed.) 15:00-16:30 *There is no research mixer.
Speaker: Hiroo Iwata ／ Manager, Strategy Research Support Section of Center of Innovation Program, Kyoto U.
Title: Cell Lego
Speaker: Peilin Chen ／ Research Fellow, Research Center for Applied Sciences, Academia Sinica, Taiwan.
Title: Isolation of Rare Cells: Toward Noninvasive Diagnostic
【Report】COINS' venture company Braizon Therapeutics, Inc. was selected as one of the ten startups as the recipients of support measures under the first round of a call for applicants for the FY2019 IP. They will be able to receive support of an “IP Mentoring Team” consisting of selected experts in the fields of business and IP for help to develop IP strategies for accelerating their businesses.
【Report】Interviews with COINS venture companies Blazon Therapeutics, Inc. and President Mariko Tosu were published in Nikkei Beyond Health. It describes the company's technology, which was established through the social implementation of nanomachines that can cross the blood-brain barrier, and the future prospects.
【Press release】An article commented by Prof. Yasuhiro Matsumura (National Cancer Research Center) who is a member of our center's COINS Project was published in Nikkei Business Daily Electronic Edition and Nikkei Business Daily(date of August 6, 2019).
Discovering the phenomenon of drugs gathering in cancer, maintaining the effectiveness of anticancer drugs (trajectory of innovation)
【Press release】The article about Dr. Keiji Itaka (Professor, Tokyo Medical and Dental University), who is a leader of COINS Theme 3 was appeared in Daily pharmaceutical industry.
"mRNA medicine" breaks or attention strain following nucleic acid medicine
【Report】An article commented by Prof. Yasuhiro Matsumura (National Cancer Research Center) who is a member of our center's COINS Project was published in Nihon Keizai Shimbun Electronic Edition and Nihon Keizai Shimbun (date of August 5, 2019).
Aiming for cells and tissues that interfere with the efficacy of “cancer allies”
【Activity Report】”King Skyfront Summer Science Event 2019,” organized by Kawasaki City, was held on Thursday, August 1. Click here for details
【Activity Report】In July, Participants in industrial location practical workshops, President of the Darma Persada University, Indonesia, and second-year students of Science Department, Kawasaki city Hight School for Science and Technology. Click here for details
【Report】Articles about Prof. Takahiro Ochiya (Professor, Tokyo Medical University, Visiting Researcher, National Cancer Center Research Institute)who is a member of our center's COINS project. Published in Nihon Keizai Shimbun Electronic Edition and Nihon Keizai Shimbun (date of July 31, 2019) .
Early cancer test in blood, "garbage" breaks through (report), can cancer be overcome (3)
【Activity Report】July 31 (Wed.), COINS Seminar #46 was held at iCONM.
Speaker: Dr. Nuno M. Neves
Associate Professor, University of Minho / Vice Director of 3B’s.
Title: "Nanoparticles and Nanofibrous Scaffolds Combined with Stem Cells for Advanced Therapies" Click here for details
【Information 】We will hold the COINS Seminar #46 at iCONM.
July 31 (Wed.) 16:00-17:00 *There is no research mixer.
Speaker: Nuno M. Neves
Associate Professor, University of Minho /Vice Director of 3B's.
Title: Nanoparticles and Nanofibrous Scaffolds Combined with Stem Cells for Advanced Therapies
Venue: Innovation Center of NanoMedicine (iCONM) 3F 3001 Access Click here for details *Registration is now closed.
【Report】An article about Prof. Yasuhiro Matsumura (National Cancer Research Center), member of our center's COINS project, was published in the evening paper Fuji.
26th：A new treatment "DDS" that strikes cancer cells and breaks through barriers
27th：Interstitial Targeting Therapy to Challenge High-grade Cancer
【Activity Report】Mr. Iwasaki, Vice-Director gave a lecture at “International Modern Hospital Show 2019”. Related page is here.
【Activity Report】<Prof. Kataoka gave a keynote speech at "Symposium on Innovative Polymers for the Nanomedicine of the 21st Century">
At "Symposium on Innovative Polymers for the Nanomedicine of the 21st Century" held at Jena in Germany on July 15-17, Prof. Kazunori Kataoka gave a keynote speech entitled as "Self-assembled supramolecular nanosystems for smart diagnosis and targeted therapy of intractable diseases". Around 140 experts in the field of nanomedicine met at the Symposium and the current state of research was recapitulated and new perspectives were actively discussed. Related page is here.
【Report】The article about the research team of Dr. Keiji Itaka (Professor, Tokyo Medical and Dental University), who is a leader of COINS Theme 3 was appeared in Nikkei Shimbun Electronic version and Nihon Keizai Shimbun morning page 10 (date of July 15, 2019).
Recovery by spinal cord injury mouse RNA administration
【Report】The article about the research which has beem carrying out at COINS in iCONM was appeared in Nikkei Shimbun Electronic version and Nihon Keizai Shimbun morning page 10 (date of July 15, 2019).
Brain gene therapy, clinical trials progress Alzheimer's and ALS overseas leader, Japan is mass production issue
【Report】An interview article by Dr. Kataoka (The University of Tokyo) has been published in the magazine Pharmaceutical Economics. It describes the background that Dr. Kataoka has spent and the elements that are necessary for a successful medical-industrial collaboration.
From DDS to "In Body Hospitals" Practitioner of medical-industrial collaboration 2 Kazunori Kataoka Director, Center for Nanomedical Innovation.
【Press release】The article about the research team of Dr. Keiji Itaka (Professor, Tokyo Medical and Dental University), who is a leader of COINS Theme 3 was appeared in Qlife Pro.
【Press release】Tokyo Medical and Dental Universiy has made a press release that a manuscript "Enhancement of Motor Function Recovery After Spinal Cord Injury in Mice by Delivery of Brain Derived Neurotrophic Factor mRNA" by Dr. Keiji Itaka, COINS theme 3 leader, Professor, Tokyo Medial and Dental University, et al. has been published online in "Molecular Therapy-Nucleic Acids" on June 28, 2019. Press release text
【Press release】"Nanomachines that carry nucleic acid medicine for fundamental treatment of hereditary intractable disease. Launched crowdfunding for R&D and disease enlightenment."
・Start research and development of nucleic acid medicines that lead to fundamental treatment of designated intractable disease "cystic fibrosis".
・Start recruitment of crowdfunding in partnership with Academia Mist.
・The recruitment period is between June 28-August 26. The target amount is ¥ 400,000.
・Expect to connect not only to raising research funding but also to social enlightenment of “cystic fibrosis”. Press release text
Cystic fibrosis is a rare disease that occurs at a rate of 1 in 600,000 people in Japan, and highly viscous secretions are excessively secreted in major organs throughout the body, such as the lungs and the pancreas. It is a disease that causes various pains such as dyspnea and digestive disorders.
Currently, there is no drug effective for the fundamental treatment, and it is classified as a designated intractable disease by the Ministry of Health, Labor and Welfare.
Your support is very much appreciated. Please click here for details.
【Activity Report】June 25th (Tue.), COINS Seminar #45 was held at iCONM.
Speaker: Dr. Makoto Miyagishi
Group Leader, Molecular Composite Medicine Research Group,
Biomedical Research Institute, Advanced Industrial Science and Technology (AIST)
Title: " Development of screening method of nucleic acid aptamer, and its application to finding of DNA/RNA catalyst" Click here for details
【Report】Announcing a new choice of startup support program "J-Startup" by public and private!
The Ministry of Economy, Trade and Industry has newly identified 49 companies as startup support companies and announced their press.
COINS's venture company Brazon Therapeutics is among the 49 companies. About the selection of "J-Startup 2019" | Ministry of Economy, Trade and Industry
【News Coverage】Director General, Dr. Kazunori Kataoka (Professor, The University of Tokyo）gave a talk at Link-J Networking Reception UCLA Health : Partnering with Industry to Advance Healthcare that held on 5/16. He talked about the academic exchange with UCLA that lasts for more than a decade.
【Report】AccuRna, Inc. one of the participating institutions announced that they will start
clinical trials for breast cancer treatment with SiRNA based nucleic acid medicines later this year.
AccuRna starts triple negative breast cancer (TNBC) treatment with nucleic acid medicines. | The Chemical Daily
【Award】Takuya Nishizono (The University of Tokyo) received the Polymer Society of Japan Excellent Poster Award at the 68th SPSJ Annual Meeting Best poster award.
Title：Evaluation on brain accumulation and distribution of nanocarriers with different sizes
【Award】Yoshihiro Tachihara (The University of Tokyo) received the Polymer Society of Japan Excellent Poster Award at the 68th SPSJ Annual Meeting Best poster award.
Title：Development of pH-Sensitive Polymeric Micelles for Targeted Delivery of the Macrocycle Valinomycin via Host Guest Interaction
【Activity Report】Mr. Watanabe, President of Kiraboshi Bank, new members of the Kawasaki City Council and members of Kihara Foundation Bio Venture Alliance visited iCONM in May. Detailed page below
【Information】Professor Kazunori Kataoka, Director General of iCONM, was installed as an Honorary Member of the Society of Polymer Science, Japan.
【Information 】We will hold the COINS Seminar #45 at iCONM.
June 25th (Tue.) 16:00–17:15 (Research Mixer 17:15～18:15 *JPY500)
Speaker: Dr. Makoto Miyagishi
Group Leader, Molecular Composite Medicine Research Group, Biomedical Research Institute, Advanced Industrial Science and Technology (AIST).
Title: Development of screening method of nucleic acid aptamer, and its application to finding of DNA/RNA catalyst
Venue: Innovation Center of NanoMedicine (iCONM) 3F 3001 Access
【Activity Report】May 14th (Tue.), COINS Seminar #44 was held at iCONM.
Speaker: Dr. Hiroyuki Fujita
Professor, Tokyo City University, Advanced Research Lab.
Title: "MEMS Technology and Applications to Biomedical Field" Click here for details
【TV】Director General, Dr. Kazunori Kataoka (Professor, The University of Tokyo) is going to appear on TV program!
29 April 8:00-10:30 AM Nippon Televison 『Sukkiri』
【TV】Vice Director, Mr. Hirokazu Iwasaki is going to appear on TV program tomorrow!
26 April 6:00PM TVK 『NEWS Harbor』
【Press Release】We held a press conference by Kazunori KATAOKA（Director General, iCONM / Professor, The of Tokyo）and Kanjiro MIYATA, COINS Theme 1 leader（Associate Professor, The University of Tokyo / Visiting Scientist, iCONM）. They succeeded in developing the Nucleic Acid Medicine-loaded Nanomachine, a technology that can stably protect nucleic acid drugs that are prone to deactivation in the bloodstream and deliver them to intractable cancers such as pancreatic cancer and brain tumors. Click here for details.
This research result was published in "Nature Communications (UK scientific journal)" on Wednessday, April 24, 2019.
【Activity Report】Ministry of Finance, Budget Bureau and MEXT visited iCONM in mid-April. Detailed page below
【Activity Report】COINS Seminar #43 was held at Kawasaki King Skyfront Tokyu REI Hotel.
Speaker: Mr. Kazuomi Iwatani
Manager, Intellectual Property Division
Japan Agency for Medical Research and Development（AMED）
Title: "The briefing session of support program by Intellectual Property Division of AMED"
Speaker: Dr. Hiroatsu Nohara
Associated Researcher, Affiliation: Lest-CNRS / Aix-Marseille University
Title: "French medical cluster: the case of “Oncopole” in Toulouse" Click here for details
【Information】We will hold the COINS Seminar #44 at iCONM.
May 14th (Tue.) 16:00–17:15 (Research Mixer 17:15-18:15 *JPY500)
Speaker: Dr. Hiroyuki Fujita
Professor, Tokyo City University, Advanced Research Lab.
Title: MEMS Technology and Applications to Biomedical Field
【Information】COINS SDGs promotion video has been completed. This is request from JST.
We are proactively contributing to the achievement of the SDGs goal 3 of "Good health and well-being". We hope you enjoy it!
What is the SDGs?：
The 2030 Agenda for Sustainable Development (the 2030 Agenda) is a set of international development goals from 2016 to 2030, which was adopted by the UN Sustainable Development Summit held in September 2015 building on the success of Millennium Development Goals (MDGs).
You can see more details from Ministry of Foreign Affairs of Japan HP
【News Coverage】Director General, Dr. Kazunori Kataoka (Professor, The University of Tokyo）'s interview was introduced on THEMIS magazine (1 April).
Dr. Kazunori Kataoka, Director-General, Innovation Center of NanoMedicine faces the challenge to eliminate cancer and Alzheimer's disease with polymer micelle